Successful Treatment of Autoimmune Hemolytic Anemia with Steroid, IVIg, and Plasmapheresis in a Haploidentical Transplant Recipient
Journal Title: Turkish Journal of Hematology - Year 2012, Vol 29, Issue 2
Abstract
To the Editor, Autoimmune hemolytic anemia (AIHA) is a rare, but clinically significant complication following hematopoietic stem cell transplantation (HSCT). It is characterized by hemolysis due to antibodies produced by the donor’s immune system against donor red cell antigens. The 3-year cumulative incidence of AIHA is 4.44% in adults; however, 75% of patients develop AIHA during the first post-HSCT year [1]. AIHA after allogeneic HSCT has been associated with a variety of conditions, including chronic graft-versus-host disease (GVHD) [2], T-cell depletion [3], and unrelated donor transplants [4]. HSCT from unrelated donors and the development of chronic extensive GVHD were the only independent factors associated with AIHA [1]; however, the incidence of and risk factors for AIHA, as well as its prognosis and response to treatment remain unclear.
Authors and Affiliations
Burak Uz, Evren Özdemir, Salih Aksu, Tülay Akyol, Roy Jones
Keywords
Related Articles
- EP ID EP142672
- DOI 10.5505/tjh.2012.78055
- Views 65
- Downloads 0
Adsorptive Leukocytapheresis in Inflammatory Bowel Diseases: Our Preliminary Results are Encouraging
To the Editor, Infl ammatory bowel disease (IBD), consisting of ulcerative colitis (UC) and Crohn’s disease (CD), is a chronic recurrent disorder with unclear etiology. A close relation to autoimmune status featured by...
Vinkristin Nöropatisinin Nadir Manifestasyonları: Hodgkin Lenfomalı İki Olgu Raporu
Lenalidomide-Induced Pure Red Cell Aplasia
Otolog Kök Hücre Naklini Takiben Gelişen Hipotiroidi Vakası
Screening of Intron 1 Inversion of the Factor VIII Gene in 130 Patients with Severe Hemophilia A from a Pakistani Cohort
To the Editor,